Abstract
This study examined the association between digoxin use and subsequent psoriasis risk using a population-based database in Taiwan. This cohort study enrolled 15 545 digoxin users and 15 545 propensity score-matched non-users from the Taiwan National Health Insurance Research Database. Each patient was independently followed up for 5 years to confirm whether they had been diagnosed with psoriasis. Cox proportional hazard regression was used to estimate psoriasis risk among digoxin users. Subgroup and sensitivity analyses were also performed. The psoriasis incidence rates were 3.02 and 2.27 per 1000 person-years among digoxin users and non-users, respectively. After adjustment for confounders, psoriasis risk was significantly higher among digoxin users than among non-users. Notably, in most subgroup analyses, digoxin use tended to increase psoriasis risk, particularly among patients with heart failure, diabetes, hypertension and hyperlipidaemia. Moreover, significantly increased psoriasis risk was noted over 2, 3, 4 and 5 years of digoxin use. In conclusion, our findings confirm that digoxin use increases subsequent psoriasis risk. Thus, physicians should be aware of this association and accordingly estimate the risks and benefit...Continue Reading
References
Jun 1, 1990·Journal of Autoimmunity·L JanssonR Holmdahl
Nov 1, 1986·Journal of the American Academy of Dermatology·E A AbelE M Farber
Dec 1, 1981·Journal of the American Academy of Dermatology·M DavidJ Grinblatt
Nov 13, 2001·American Journal of Clinical Dermatology·N TsankovJ Kazandjieva
Nov 14, 2001·American Journal of Clinical Dermatology·O Dereure
May 15, 2002·Progress in Cardiovascular Diseases·Eric J Eichhorn, Mihai Gheorghiade
Jul 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elisabetta VegetoAdriana Maggi
Jul 21, 2007·Endocrine Reviews·Rainer H Straub
Jul 31, 2007·Lancet·Christopher Em Griffiths, Jonathan Nwn Barker
Mar 4, 2008·Journal of the American Academy of Dermatology·Alexa B KimballUNKNOWN National Psoriasis Foundation
Dec 6, 2008·Breast Cancer Research : BCR·Thomas P AhernLars Pedersen
Jul 31, 2009·The New England Journal of Medicine·Frank O NestleJonathan Barker
Apr 20, 2010·Annals of the New York Academy of Sciences·Maurizio CutoloPier Carlo Sarzi Puttini
Nov 3, 2010·BMJ : British Medical Journal·A D BurdenUNKNOWN Guideline Development Group
Nov 26, 2010·International Journal of Dermatology·Kabbur Hanumanthappa BasavarajThaggikuppe Krishnamurthy Praveen
Mar 29, 2011·Nature·Jun R HuhDan R Littman
Dec 14, 2011·Autoimmunity Reviews·Maurizio CutoloRainer H Straub
Mar 1, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert J Biggar
Jan 15, 2015·Cytokine·Jaymie BaliwagAndrew Johnston
Sep 1, 2015·BMJ : British Medical Journal·Oliver J ZiffDipak Kotecha
Dec 15, 2015·Acta Dermato-venereologica·Shaowei WuAbrar A Qureshi
Feb 18, 2016·British Journal of Pharmacology·Huairui ShiQiutang Zeng
May 10, 2016·Trends in Cardiovascular Medicine·Oliver J Ziff, Dipak Kotecha
Feb 19, 2017·Journal of the American Academy of Dermatology·Junko TakeshitaJoel M Gelfand
May 31, 2017·The British Journal of Dermatology·C E M GriffithsM Augustin
Sep 10, 2017·The Journal of Allergy and Clinical Immunology·Jason E HawkesJames G Krueger
Sep 14, 2017·JAMA Dermatology·April W Armstrong
Feb 2, 2018·Psoriasis : Targets and Therapy·Deepak Mw Balak, Enes Hajdarbegovic